Fudan Zhangjiang: The acceptance notice for the application for the market of oral solution powder of amornul pentanoate hydrochloride for visualizing brain glioma surgery.

Fudan Zhangjiang Announcement: Fudan Zhangjiang Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received a "Notice of Acceptance" issued by the National Medical Products Administration recently. The application for marketing approval of the powder for oral solution of amphotericin B for visualizing malignant tissue during surgery in adult patients with malignant high-grade glioma has been accepted.